Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Cash Flow Quality Index
Latest as of September 2023:
-0.95x
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Cash Flow Quality Index of -0.95x as of September 2023. Operating cash flow of $-10.75 Million is below net income of $11.28 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ARTV long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.95x
Operating CF / Net Income
Operating Cash Flow
$-10.75 Million
USD
Net Income
$11.28 Million
USD
Data as of
Sep 2023
Most recent filing
Annual Cash Flow Quality Index for Artiva Biotherapeutics, Inc. Common Stock (None–None)
Year-by-year earnings quality comparison for Artiva Biotherapeutics, Inc. Common Stock. For live market cap and the full company financial profile, see Artiva Biotherapeutics, Inc. Common Stoc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.